Business Description
MiNK Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US6036931029
Description
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.37 | |||||
| Equity-to-Asset | -2.38 | |||||
| Debt-to-Equity | -0.26 | |||||
| Debt-to-EBITDA | -0.33 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -10.9 | |||||
| 3-Year EPS without NRI Growth Rate | -4.4 | |||||
| 3-Year FCF Growth Rate | -15.8 | |||||
| 3-Year Book Growth Rate | 35 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 21.83 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.01 | |||||
| 9-Day RSI | 36.98 | |||||
| 14-Day RSI | 35.51 | |||||
| 6-1 Month Momentum % | -24.44 | |||||
| 12-1 Month Momentum % | -32.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.89 | |||||
| Quick Ratio | 0.89 | |||||
| Cash Ratio | 0.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.8 | |||||
| Shareholder Yield % | -27.72 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -188.23 | |||||
| ROIC % | -439.24 | |||||
| ROC (Joel Greenblatt) % | -1590.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.24 | |||||
| EV-to-Forward-EBIT | -1.29 | |||||
| EV-to-EBITDA | -1.26 | |||||
| EV-to-FCF | -1.63 | |||||
| Earnings Yield (Greenblatt) % | -80.65 | |||||
| FCF Yield % | -51.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INKT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MiNK Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.38 | ||
| Beta | 0.04 | ||
| Volatility % | 27.59 | ||
| 14-Day RSI | 35.51 | ||
| 14-Day ATR ($) | 0.057133 | ||
| 20-Day SMA ($) | 0.627703 | ||
| 12-1 Month Momentum % | -32.67 | ||
| 52-Week Range ($) | 0.4632 - 1.9 | ||
| Shares Outstanding (Mil) | 39.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MiNK Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MiNK Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MiNK Therapeutics Inc Frequently Asked Questions
What is MiNK Therapeutics Inc(INKT)'s stock price today?
The current price of INKT is $0.53. The 52 week high of INKT is $1.90 and 52 week low is $0.46.
When is next earnings date of MiNK Therapeutics Inc(INKT)?
The next earnings date of MiNK Therapeutics Inc(INKT) is 2025-03-21 Est..
Does MiNK Therapeutics Inc(INKT) pay dividends? If so, how much?
MiNK Therapeutics Inc(INKT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers